Literature DB >> 8684217

Mucosa-associated lymphoid tissue lymphoma of the oesophagus.

A M Soweid, P E Zachary.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8684217     DOI： 10.1016/s0140-6736(05)65577-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Radiotherapy for mucosa-associated lymphoid tissue (MALT) lymphoma of the esophagus: a case report with a diagnostic and therapeutic discussion.

Authors:  Kazushi Kishi; Hiroki Maeda; Yasushi Nakamura; Shintaro Shirai; Morio Sato
Journal:  Int J Clin Oncol       Date:  2011-06-10       Impact factor: 3.402

2.  Mucosa-associated lymphoid tissue (MALT) lymphoma arising in the esophagus, stomach, and lung.

Authors:  Masataro Hayashi; Kazuhiro Ueda; Toshiki Tanaka; Tadahiko Enoki; Nobuyuki Tanaka; Toshikazu Gondo; Kimikazu Hamano
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-12-16

3.  Mucosa-associated lymphoid tissue of nasopharynx: A case report and literature review.

Authors:  Tianci Tang; Xiaochen Ni; Xinmao Song
Journal:  Radiol Case Rep       Date:  2022-06-17

Review 4.  A case of primary low grade mucosa associated lymphoid tissue (MALT) lymphoma of the oesophagus.

Authors:  S Hosaka; N Nakamura; T Akamatsu; T Fujisawa; Y Ogiwara; K Kiyosawa; E Hidaka; H Ota; T Katsuyama; H Inagaki
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

Review 5.  Primary esophageal mucosa-associated lymphoid tissue lymphoma: A case report and review of literature.

Authors:  Qiang Ma; Chun Zhang; San'gao Fang; Peng Zhong; Xiangfeng Zhu; Li Lin; Hualiang Xiao
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

6.  Primary Localized Esophageal Mucosa-associated Lymphoid Tissue Lymphoma Treated by Endoscopic Submucosal Dissection.

Authors:  Sayo Kobayashi; Masaya Iwamuro; Kenji Nishida; Takehiro Tanaka; Seiji Kawano; Yoshiro Kawahara; Tadashi Yoshino; Hiroyuki Okada
Journal:  Intern Med       Date:  2018-03-30       Impact factor: 1.271
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.